Hydrocortisone Sodium Succinate for Injection — Class II drug recall D-0039-2027
Ongoing recall by Zydus Pharmaceuticals (USA) Inc, reported 2026-10-21, distributed nationwide. Failed Impurities/Degradation Specifications.
| Recall number | D-0039-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc, Pennington, NJ, United States |
| Recall initiated | 2026-10-01 |
| Classified | 2026-10-13 |
| Reported by FDA | 2026-10-21 |
| Distributed | Nationwide (US) |
| Quantity | 70,776 vials |
| Reason classes | specification failure |
| NDC | 70710-1907, 70710-1907-01 |
| Lot numbers | LB00047A, LB00048A |
| Expiration dates | 2028-03 |
Product
Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1907-1.
Reason for recall
Failed Impurities/Degradation Specifications.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0039-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-27. Not affiliated with or endorsed by FDA. Not medical or legal advice.